Sequence-specific, Nucleic-acid Hydrolyzing Antibody Degrades Viral Genome RNA and Inhibits the Replication of Influenza H9N2 Virus without Significant Cytotoxicity to Host Cell
Aeyung KIM, Tae-Hwan SHIN, Seung-Min SHIN, Yong-Sung KIM
언어
일본어(JPN)
URL
https://www.earticle.net/Article/A174872
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Influenza NP is essential to viral replication, providing an ideal target for antiviral therapy. NP has been targeted at the protein level for antiviral therapy by a small molecule, but it is extremely difficult to be targeted by antibody since it is not exposed at the viral surface. Here we present a novel antibody-based antiviral strategy of targeting viral genomic RNA (vRNA) for degradation rather than neutralizing viral proteins. Based on the template of a seqeunce-nonspecific nucleic acid-hydrolyzing, single domain antibody of the light chain variable domain, 3D8 VL, we generated a synthetic library on the yeast surface by randomizing putative nucleic acid interacting residues. To target nucleocapsid protein (NP)- encoding viral genomic RNA (NP-vRNA) of H9N2 influenza virus, the library was screened against a 18- nucleotide single stranded nucleic acid substrate, dubbed asNP18, the sequence of which is unique to the NP- vRNA. We isolated a 3D8 VL variant, NP25, that had ~15-fold higher affinity (~54 nM) and ~3-fold greater selective hydrolyzing activity for the target substrate than for off targets. In contrast to 3D8 VL WT, asNP18 -selective NP25 constitutively expressed in the cytosol of human lung carcinoma A549 cells does not exhibit any signficant cytotoxicity and selectively degrades a reporter mRNA carrying the target asNP18 sequence in the stable cell lines. NP25 more potently inhibits the replication of H9N2 influenza virus than 3D8 VL WT in the stable cell lines. NP25 more selectively reduces the amount of the targeted NP-vRNA than 3D8 VL WT from the early stage of virus infection in the stable cell lines, without noticeable harmful effects on the endogenous mRNA, suggesting that NP25 indeed more specifically recognizes to hydrolyze the target NP-vRNA of H9N2 virus than off-targets. Our results provide a proof-of-concept of targeting viral genomic vRNAs by the sequence-specific nucleic acid hydrolyzing antibody for the prevention and control of influenza A virus infection in humans and animals.
키워드
influenza A virusH9N2 virusgenome targetingnucleocapsid proteincatalytic antibody
저자
Aeyung KIM [ Dept. of Molecular Science and Technology, Ajou University, Suwon, 443-749. ]
Tae-Hwan SHIN [ Dept. of Molecular Science and Technology, Ajou University, Suwon, 443-749. ]
Seung-Min SHIN [ Dept. of Molecular Science and Technology, Ajou University, Suwon, 443-749. ]
Yong-Sung KIM [ Dept. of Molecular Science and Technology, Ajou University, Suwon, 443-749. ]
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동